Former Chief Financial Officer · Cytek Biosciences, Inc. (CTKB)

Patrik Jeanmonod

A named executive officer of Cytek Biosciences in every fiscal year CompBrief holds from FY2020 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$758,171

Salary $297,833Stock awards $249,993

FY2023: $1,786,088

7th of 7 named executive officers at Cytek Biosciences by FY2024 total.

7 named officers on file for Cytek Biosciences, FY2024

Patrik Jeanmonod’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • CTKB’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cytek Biosciences’s whole pay program stands against its peers

  • Cytek Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CTKB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Patrik Jeanmonod’s full pay file as a PDF — free

More than this page: up to 10 years of Patrik’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Patrik Jeanmonod compensation by year

Cytek Biosciences Summary Compensation Table · all 4 fiscal years held
In US dollars, as Cytek Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2023FY2024
Salary$241,193$292,865$408,000$297,833
Bonus$88,066$106,492$0$0
Stock awards$0—$625,000$249,993
Option awards$25,048$2,125,000$625,000$149,996
Non-equity incentive$0—$109,901$46,998
Pension and deferred compensation$0—$0$0
All other$10,854$13,179$18,187$13,350
Total$365,161$2,550,715$1,786,088$758,171

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cytek Biosciences, Inc. DEF 14A filed April 28, 2025, accession 0001140361-25-016032, and prior-year filings.

How this page was built: the Cytek Biosciences, Inc. filed document, accession 0001140361-25-016032. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

$365K
$2.6M
$1.8M
$758K
FY20
FY21
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU125,000$350,000—
RSU34,366$223,035—
RSU21,239$137,841—
RSU8,186$53,127—
Option18,230—$17.00
Option11,460—$13.64
Option30,948—$6.18
Option50,080—$10.61

Per the Outstanding Equity Awards at Fiscal Year-End table in Cytek Biosciences, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Cytek Biosciences’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Wenbin JiangChief Executive Officer and President$6,084,671
Valerie BarnettChief Legal Officer and Corporate Secretary$2,410,489
Chris WilliamsFormer Chief Operating Officer$2,338,447
Ming YanChief Technology Officer$1,856,550
William McCombeChief Financial Officer$1,689,261
Philippe BusqueSenior Vice President, Global Sales and Services$1,004,760
Patrik Jeanmonod · this pageFormer Chief Financial Officer$758,171

The full Cytek Biosciences compensation record

free company brief

This page is one person within Cytek Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Cytek Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cytek Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Patrik Jeanmonod's compensation dossier · One-time report. No refunds.